Adding nutritional status to the original BCLC stage improves mortality prediction for hepatocellular carcinoma patients in HBV-endemic regions.
Am J Cancer Res
; 13(8): 3618-3628, 2023.
Article
en En
| MEDLINE
| ID: mdl-37693156
5-fold cross-validation; Barcelona Clinic Liver Cancer (BCLC) stage; Hepatocellular carcinoma (HCC); albumin-bilirubin (ALBI) score; area under receiver operating characteristic curve (AUROC); internal and external validation; model building; neutrophil-lymphocyte ratio (NLR); nutritional status; short-term mortality; subgroup sensitivity analysis
Texto completo:
1
Colección:
01-internacional
Banco de datos:
MEDLINE
Tipo de estudio:
Prognostic_studies
/
Risk_factors_studies
Idioma:
En
Revista:
Am J Cancer Res
Año:
2023
Tipo del documento:
Article
País de afiliación:
Taiwán